MD2852C2 - Использование будесонида для лечения резистентного асцита у больных с циррозом печени - Google Patents
Использование будесонида для лечения резистентного асцита у больных с циррозом печени Download PDFInfo
- Publication number
- MD2852C2 MD2852C2 MDA20050089A MD20050089A MD2852C2 MD 2852 C2 MD2852 C2 MD 2852C2 MD A20050089 A MDA20050089 A MD A20050089A MD 20050089 A MD20050089 A MD 20050089A MD 2852 C2 MD2852 C2 MD 2852C2
- Authority
- MD
- Moldova
- Prior art keywords
- budesonide
- treatment
- hepatic cirrhosis
- pacients
- resistant ascites
- Prior art date
Links
- 206010003445 Ascites Diseases 0.000 title abstract 3
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 title abstract 2
- 229960004436 budesonide Drugs 0.000 title abstract 2
- 208000019425 cirrhosis of liver Diseases 0.000 title abstract 2
- 210000000683 abdominal cavity Anatomy 0.000 abstract 1
- 238000009825 accumulation Methods 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000006020 chronic inflammation Effects 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 210000003200 peritoneal cavity Anatomy 0.000 abstract 1
- 230000035699 permeability Effects 0.000 abstract 1
- 230000002792 vascular Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Изобретение относится к медицине, в частности к гепатологии.Сущность изобретения состоит в использовании будесонида для лечения резистентного асцита у больных с декомпенсированным циррозом печени.Результат изобретения состоит в уменьшении регионального хронического воспалительного процесса за счет уменьшения проницаемости сосудистой стенки и транссудации жидкости в интерстициальном пространстве органов брюшной полости и предотвращает ее накопление в перитонеальной полости, которая ведет к формированию резистентного асцита.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20050089A MD2852C2 (ru) | 2005-03-28 | 2005-03-28 | Использование будесонида для лечения резистентного асцита у больных с циррозом печени |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20050089A MD2852C2 (ru) | 2005-03-28 | 2005-03-28 | Использование будесонида для лечения резистентного асцита у больных с циррозом печени |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD2852B1 MD2852B1 (en) | 2005-09-30 |
| MD2852C2 true MD2852C2 (ru) | 2006-04-30 |
Family
ID=35057532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDA20050089A MD2852C2 (ru) | 2005-03-28 | 2005-03-28 | Использование будесонида для лечения резистентного асцита у больных с циррозом печени |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD2852C2 (ru) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19742612A1 (de) * | 1997-09-26 | 1999-04-01 | Falk Pharma Gmbh | Budesonid zur Behandlung von cholestatischen Lebererkrankungen |
| WO1999039699A1 (en) * | 1998-02-09 | 1999-08-12 | Rtp Pharma, Inc. | Treatment of chronic inflammatory disorders of the gastrointestinal tract |
-
2005
- 2005-03-28 MD MDA20050089A patent/MD2852C2/ru not_active IP Right Cessation
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19742612A1 (de) * | 1997-09-26 | 1999-04-01 | Falk Pharma Gmbh | Budesonid zur Behandlung von cholestatischen Lebererkrankungen |
| WO1999039699A1 (en) * | 1998-02-09 | 1999-08-12 | Rtp Pharma, Inc. | Treatment of chronic inflammatory disorders of the gastrointestinal tract |
Non-Patent Citations (1)
| Title |
|---|
| Spencer C., Mc. Tavish D. Budesonide. A review of its pharmacological properties and therapeutic efficacy in inflammatory bowel disease. Drugs, 1995, vol. 50, p. 854-872 * |
Also Published As
| Publication number | Publication date |
|---|---|
| MD2852B1 (en) | 2005-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2760371A4 (en) | VENTRICULAR TRANSCATHETER RECONSTRUCTION STRUCTURES, METHODS AND SYSTEMS FOR THE TREATMENT OF CONGESTIVE HEART FAILURE AND OTHER SUFFERING | |
| SG11202010070QA (en) | Corrosion-resistant permanent magnet and intravascular blood pump comprising the magnet | |
| IL236356A0 (en) | Use of iron citrate to treat patients with chronic kidney disease | |
| MX2013010387A (es) | Sistema de vacio y disposicion de endoscopia para la terapia endoscopica al vacio. | |
| MX360302B (es) | Combinacion de doble barril e injerto de estent desramificante y métodos para su uso. | |
| EP2578233A4 (en) | THERAPEUTIC AGENT AGAINST PANCREAS CANCER | |
| UA108198C2 (ru) | Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение | |
| IN2015DN00437A (ru) | ||
| MX2015013944A (es) | Inhibidor de quinasa. | |
| FR3005564B1 (fr) | Instrument destine a etre utlise pour modifier le volume de l'estomac d'un patient. | |
| MX390363B (es) | Combinacion de linagliptina y metformina | |
| EP2148675A4 (en) | ANTI-CANCER FOR THE DIAGNOSIS AND TREATMENT OF CANCER | |
| EP2329044A4 (en) | PRMT1 FOR TARGET GENES TO CANCER THERAPY AND DIAGNOSIS | |
| EP4279925A3 (en) | Dulaglutide for the treatment of chronic kidney disease | |
| IL236776A0 (en) | Use of antithrombin in extracorporeal membrane oxidation | |
| WO2007023154A3 (de) | EISEN(III)-KOMPLEXVERBINDtMGEN ZUR BEHANDLUNG VON EISENMANGEL-ZUSTÄNDEN BEI PATIENTEN MIT CHRONISCH-ENTZÜNDLICHER DARMERKRANKUNG | |
| de Franciscis et al. | Matrix metalloproteinases and endothelial dysfunction: the search for new prognostic markers and for new therapeutic targets for vascular wall imbalance | |
| EP2167071A4 (en) | BACLOFEN SOLUTION FOR LOW VOLUME THERAPEUTIC DELIVERY | |
| MD2852C2 (ru) | Использование будесонида для лечения резистентного асцита у больных с циррозом печени | |
| EP3349731A4 (en) | COMBINATION OF TOPOISOMERASE I INHIBITORS WITH IMMUNOTHERAPY IN THE TREATMENT OF CANCER | |
| WO2016029001A3 (en) | Antibodies to polyphosphate decrease clot formation, decrease inflammation, and improve survival | |
| EP2455079A4 (en) | COMPOSITION FOR THE PREVENTION OR TREATMENT OF BONE DISEASES WITH COLFORSINE DAROPATE | |
| EP2136820A4 (en) | TARGET FOR BREAST CANCER THERAPY AND / OR DIAGNOSIS | |
| MD774Y (ru) | Метод эндоскопического лечения спонтанного циррогенного асцит-перитонита | |
| EP1843781A4 (en) | COMPOSITION FOR THE PREVENTION, TREATMENT AND DIAGNOSIS OF INFLAMMATORY CHRONIC DISEASES OF AIRWAYS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
| MM4A | Patent for invention definitely lapsed due to non-payment of fees |